Calcipotriol
- Generic Name
- Calcipotriol
- Brand Names
- Calcitrene, Dovobet, Dovonex, Enstilar, Sorilux, Taclonex, Wynzora
- Drug Type
- Small Molecule
- Chemical Formula
- C27H40O3
- CAS Number
- 112965-21-6
- Unique Ingredient Identifier
- 143NQ3779B
- Background
Calcipotriol (INN) or calcipotriene (USAN) is a sythetic derivative of calcitriol or Vitamin D.
- Indication
For the treatment of moderate plaque psoriasis in adults.
- Associated Conditions
- Plaque psoriasis of the scalp, Psoriasis Vulgaris (Plaque Psoriasis)
- Associated Therapies
- -
Topical Calcipotriol Versus Narrowband Ultraviolet B in Treatment of Alopecia Areata
- Conditions
- Interventions
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- Aswan University Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT03847441
- Locations
- 🇪🇬
Aswan University Hospital, Aswan, Egypt
Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene
- Conditions
- Interventions
- First Posted Date
- 2018-02-27
- Last Posted Date
- 2019-02-08
- Lead Sponsor
- Sienna Biopharmaceuticals
- Target Recruit Count
- 73
- Registration Number
- NCT03448081
- Locations
- 🇺🇸
Site 015, Sanford, Florida, United States
🇺🇸Site 013, Coral Gables, Florida, United States
🇨🇦Sienna 003, Montreal, Quebec, Canada
Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis
- First Posted Date
- 2018-02-22
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- L.H. Kircik, M.D.
- Target Recruit Count
- 28
- Registration Number
- NCT03441789
- Locations
- 🇺🇸
Center for Dermatology and Laser Surgery, Sacramento, California, United States
🇺🇸Skin Sciences, PLLC, Louisville, Kentucky, United States
🇺🇸Dermatology & Laser Center of Charleston, Charleston, South Carolina, United States
BE Study of Calcipotriene Hydrate and Betamethasone Dipropionate Topical Suspension in the Treatment of Scalp Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2018-03-07
- Lead Sponsor
- Tolmar Inc.
- Target Recruit Count
- 699
- Registration Number
- NCT03122353
- Locations
- 🇺🇸
Site 29, Fremont, California, United States
🇺🇸Site 18, Sherman Oaks, California, United States
🇺🇸Site 01, Brandon, Florida, United States
Efficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Haus Bioceuticals
- Target Recruit Count
- 28
- Registration Number
- NCT03069144
Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
- Conditions
- Interventions
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- Medical College of Wisconsin
- Registration Number
- NCT02680717
Nicotinamide in the Treatment of Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2013-01-08
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- Isfahan University of Medical Sciences
- Target Recruit Count
- 66
- Registration Number
- NCT01763424
- Locations
- 🇮🇷
Skin Diseases and Leishmaniasis Research Center, Isfahan, Iran, Islamic Republic of
Olux E Foam and Sorilux Foam Combination Therapy for the Maintenance of Treatment Response in Patients With Moderate Plaque Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2012-12-07
- Last Posted Date
- 2016-11-17
- Lead Sponsor
- Leon Kircik, M.D.
- Target Recruit Count
- 63
- Registration Number
- NCT01745133
- Locations
- 🇺🇸
DermResearch, PLLC, Louisville, Kentucky, United States
Patient Preference of Taclonex Ointment to Taclonex Scalp Suspension in Adult Subjects With Psoriasis Vulgaris
- First Posted Date
- 2012-10-15
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- Wake Forest University
- Target Recruit Count
- 20
- Registration Number
- NCT01707043
- Locations
- 🇺🇸
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"
- First Posted Date
- 2012-09-27
- Last Posted Date
- 2019-05-07
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 66
- Registration Number
- NCT01694433
- Locations
- 🇺🇸
UCLA Dermatology, Los Angeles, California, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.